查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1607168

基因克隆服务市场：按服务、应用程式和最终用户分类 - 2025-2030 年全球预测

Gene Cloning Services Market by Service (Custom Cloning Service, Gene Synthesis Service, Molecular Biology Service), Application (Gene Expression, Gene Synthesis, Gene Therapy), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

基因克隆服务市场2023年估值为23.8亿美元，预计到2024年将达到26.3亿美元，复合年增长率为11.96%，到2030年预计将达到52.5亿美元。

基因克隆服务涵盖生物技术和医学研究所必需的广泛技术和应用，旨在复製遗传物质以促进各个领域的研究。对基因克隆的需求，以复製特定基因的能力为突出，使得药物开发、农业、基因治疗和个人化医疗取得了重要进展。其应用涵盖各领域，包括製药、基因改造作物农业以及基因研究学术。生物技术公司、研究机构和临床实验室等最终用途产业正在利用基因克隆来创新和改进产品和治疗方法。

主要市场统计
基准年[2023] 23.8亿美元
预计年份 [2024] 26.3亿美元
预测年份 [2030] 52.5亿美元
复合年增长率（%） 11.96%

推动市场成长的主要因素包括生物製药需求的成长、克隆技术的技术进步以及基因研究投资的增加。最近的趋势包括CRISPR-Cas9技术，它提高了基因编辑的准确性和效率，并引起人们的关注，创造了巨大的市场机会。鼓励公司投资开发更具成本效益的克隆技术，并探索合资企业以扩大其服务组合和覆盖范围。

然而，市场面临基因操纵的伦理担忧、严格的法律规范和高昂的营运成本等挑战。这些限制可能会阻碍服务的顺利扩展。透过强有力的道德准则和监管合规性，消除公众的看法并提高基因研究的透明度，可以缓解这些挑战。

在创新方面，生物技术公司可能会专注于提高克隆效率，透过自动化和可扩展性降低成本，以及整合人工智慧来预测克隆结果。探索基于植物的克隆和微生物系统等利基市场可能会开闢新的途径。基因克隆市场的本质是动态和竞争的，受到快速技术进步和对创新解决方案的迫切需求的推动。透过利用新的科学研究，企业可以处于这一不断发展的格局的最前沿，确保永续成长并为科学进步做出重大贡献。

市场动态：揭示快速发展的基因克隆服务市场的关键市场洞察

供需的动态交互作用正在改变基因克隆服务市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 生物医学和生物技术研究的增加
    • 越来越重视基因治疗和个人化医疗
    • 药物发现和药物开发活动的增加
  • 市场限制因素
    • 与基因克隆服务相关的高成本
  • 市场机会
    • 基因工程技术不断进步
    • 扩大基因克隆在农业的应用
  • 市场挑战
    • 道德问题和熟练专业人员的短缺

波特五力：驾驭基因复製服务市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解基因克隆服务市场的外部影响

外部宏观环境因素在塑造基因克隆服务市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解基因克隆服务市场的竞争状况

基因克隆服务市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵基因克隆服务市场厂商绩效评估

FPNV 定位矩阵是评估基因克隆服务市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製基因克隆服务市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，基因克隆服务市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 生物医学和生物技术研究的进展
      • 越来越重视基因治疗和个人化医疗
      • 增加药物发现和开发活动
    • 抑制因素
      • 与基因克隆服务相关的高成本
    • 机会
      • 基因工程技术不断进步
      • 扩大基因克隆在农业的应用
    • 任务
      • 道德问题和缺乏熟练的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 基因克隆服务市场：依服务分类

  • 自订克隆服务
  • 基因合成服务
  • 分子生物学服务

第七章 基因克隆服务市场：依应用分类

  • 基因表现
  • 基因合成
  • 基因治疗
  • 疫苗调查

第八章 基因克隆服务市场：依最终用户分类

  • 学术/研究机构
  • 临床实验室
  • 製药和生物技术公司

第九章 北美和南美基因克隆服务市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太基因克隆服务市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲基因克隆服务市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Amid Biosciences
  • Aragen Life Sciences Technologies
  • Azenta US, Inc.
  • Bio-Techne Corporation
  • Canvax Reagents SL
  • Cellecta, Inc.
  • Charles River Laboratories International, Inc.
  • Creative Biogene
  • Curia
  • Eurofins Scientific SE
  • GenScript
  • Integrated DNA Technologies, Inc.
  • Lonza Group AG
  • Macrogen, Inc.
  • MedGenome Inc.
  • Merck KGaA
  • Sartorius AG
  • Sino Biological, Inc.
  • Synbio Technologies
  • Syngene International Limited
  • Takara Bio Inc.
  • Telesis Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TransGen Biotech Co., Ltd
  • Twist Bioscience Corporation
Product Code: MRR-2E76C3E47FBD

The Gene Cloning Services Market was valued at USD 2.38 billion in 2023, expected to reach USD 2.63 billion in 2024, and is projected to grow at a CAGR of 11.96%, to USD 5.25 billion by 2030.

Gene cloning services encompass a broad range of techniques and applications vital to biotechnology and medical research, aimed at reproducing genetic materials to facilitate studies in various domains. The necessity of gene cloning is underscored by its ability to replicate specific genes, enabling crucial advancements in drug development, agriculture, gene therapy, and personalized medicine. Applications span across sectors, including pharmaceuticals, agriculture for GMOs, and academia for genetic research. End-use industries such as biotechnology companies, research institutes, and clinical laboratories leverage gene cloning to innovate and refine products and therapies.

KEY MARKET STATISTICS
Base Year [2023] USD 2.38 billion
Estimated Year [2024] USD 2.63 billion
Forecast Year [2030] USD 5.25 billion
CAGR (%) 11.96%

Key factors driving market growth include the rising demand for biopharmaceuticals, technological advancements in cloning techniques, and increased investment in genetic research. Recent developments must be noted, such as CRISPR-Cas9 technology, enhancing precision and efficiency in gene editing, representing significant market opportunities. Companies are recommended to invest in developing more cost-effective cloning technologies and explore collaborative ventures to expand their service portfolios and reach.

However, the market faces challenges such as ethical concerns over genetic manipulation, stringent regulatory frameworks, and high operational costs. These limitations could hinder the smooth expansion of services. Addressing public perception and fostering transparency in genetic research through robust ethical guidelines and regulatory compliance can mitigate these challenges.

For innovation, biotech firms might focus on enhancing cloning efficiency, reducing costs through automation and scalability, and integrating AI to predict cloning outcomes. Research into niche markets like plant-based cloning and microbial systems could open new avenues. The nature of the gene cloning market is dynamic and competitive, driven by rapid technological advances and a pressing need for innovative solutions. By tapping into emerging scientific research, firms can position themselves at the forefront of this evolving landscape, ensuring sustainable growth and significant contributions to scientific advancements.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Cloning Services Market

The Gene Cloning Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in biomedical and biotechnological research
    • Growing emphasis on gene therapies and personalized medicine
    • Increase in drug discovery and development activities
  • Market Restraints
    • High cost associated with gene cloning services
  • Market Opportunities
    • Ongoing advancements in genetic engineering techniques
    • Expanding applications of gene cloning in agriculture
  • Market Challenges
    • Ethical concerns and shortage of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Gene Cloning Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Cloning Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Cloning Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Cloning Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Cloning Services Market

A detailed market share analysis in the Gene Cloning Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Cloning Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Cloning Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gene Cloning Services Market

A strategic analysis of the Gene Cloning Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gene Cloning Services Market, highlighting leading vendors and their innovative profiles. These include Amid Biosciences, Aragen Life Sciences Technologies, Azenta US, Inc., Bio-Techne Corporation, Canvax Reagents SL, Cellecta, Inc., Charles River Laboratories International, Inc., Creative Biogene, Curia, Eurofins Scientific SE, GenScript, Integrated DNA Technologies, Inc., Lonza Group AG, Macrogen, Inc., MedGenome Inc., Merck KGaA, Sartorius AG, Sino Biological, Inc., Synbio Technologies, Syngene International Limited, Takara Bio Inc., Telesis Bio Inc., Thermo Fisher Scientific Inc., TransGen Biotech Co., Ltd, and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Gene Cloning Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service, market is studied across Custom Cloning Service, Gene Synthesis Service, and Molecular Biology Service.
  • Based on Application, market is studied across Gene Expression, Gene Synthesis, Gene Therapy, and Vaccine Research.
  • Based on End User, market is studied across Academic & Research Institutions, Clinical Laboratories, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in biomedical and biotechnological research
      • 5.1.1.2. Growing emphasis on gene therapies and personalized medicine
      • 5.1.1.3. Increase in drug discovery and development activities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with gene cloning services
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in genetic engineering techniques
      • 5.1.3.2. Expanding applications of gene cloning in agriculture
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical concerns and shortage of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Gene Cloning Services Market, by Service

  • 6.1. Introduction
  • 6.2. Custom Cloning Service
  • 6.3. Gene Synthesis Service
  • 6.4. Molecular Biology Service

7. Gene Cloning Services Market, by Application

  • 7.1. Introduction
  • 7.2. Gene Expression
  • 7.3. Gene Synthesis
  • 7.4. Gene Therapy
  • 7.5. Vaccine Research

8. Gene Cloning Services Market, by End User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutions
  • 8.3. Clinical Laboratories
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Gene Cloning Services Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Gene Cloning Services Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Gene Cloning Services Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amid Biosciences
  • 2. Aragen Life Sciences Technologies
  • 3. Azenta US, Inc.
  • 4. Bio-Techne Corporation
  • 5. Canvax Reagents SL
  • 6. Cellecta, Inc.
  • 7. Charles River Laboratories International, Inc.
  • 8. Creative Biogene
  • 9. Curia
  • 10. Eurofins Scientific SE
  • 11. GenScript
  • 12. Integrated DNA Technologies, Inc.
  • 13. Lonza Group AG
  • 14. Macrogen, Inc.
  • 15. MedGenome Inc.
  • 16. Merck KGaA
  • 17. Sartorius AG
  • 18. Sino Biological, Inc.
  • 19. Synbio Technologies
  • 20. Syngene International Limited
  • 21. Takara Bio Inc.
  • 22. Telesis Bio Inc.
  • 23. Thermo Fisher Scientific Inc.
  • 24. TransGen Biotech Co., Ltd
  • 25. Twist Bioscience Corporation

LIST OF FIGURES

  • FIGURE 1. GENE CLONING SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. GENE CLONING SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENE CLONING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. GENE CLONING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. GENE CLONING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENE CLONING SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENE CLONING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENE CLONING SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY CUSTOM CLONING SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY MOLECULAR BIOLOGY SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GENE EXPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY VACCINE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. GENE CLONING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. GENE CLONING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023